Valorising and creating access to innovative medicines in the European Union

by Lieven eAnnemans, Irina eCleemput, Frank eHulstaert, Steven eSimoens
Published 2011-10-01

Industry perspectives on market access of innovative drugs

by Kim ePauwels, Isabelle eHuys, Minne eCasteels, Steven eSimoens
Published 2016-06-01

Towards a European definition for a drug shortage: a qualitative study

by Elfi eDe Weerdt, Steven eSimoens, Minne eCasteels, Isabelle eHuys
Published 2015-10-01

Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications

by James eMoon, Brian eGodman, Brian eGodman, Max ePetzold, Samantha eAlvarez-Madrazo, Kathleen eBennett, Iain eBishop, Anna eBucsics, Ulrik eHesse, Andrew eMartin, Steven eSimoens, Corinne eZara, Rickard E Malmstrom
Published 2014-10-01

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimise the use of new drugs

by Rickard eMalmstrom, Brian eGodman, Brian eGodman, Brian eGodman, Eduardo eDiogene, Christoph eBaumgaertel, Marion eBennie, Marion eBennie, Iain eBishop, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alessandra eFerrario, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Miguel eGomes, Iñaki eGutiérrez-Ibarluzea, Alan eHaycox, Krystyna eHviding, Harald eHerholz, Mikael eHoffmann, Saira eJan, Jan eJones, Roberta eJoppi, Marija eKalaba, Christina eKvalheim, Ott eLaius, Irene eLangner, Julie eLonsdale, Sven-Ake eLoov, Kamila eMalinowska, Kamila eMalinowska, Laura eMcCullagh, Ken ePaterson, Vanda eMarkovic-Pekovic, Vanda eMarkovic-Pekovic, Andrew eMartin, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Steven eSimoens, Faik Cankat Tulunay, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Michael eWilcock, Magda eWladysiuk, Menno van Woerkom, Corrine eZara, Lars L Gustafsson
Published 2013-05-01